Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1801 (113th)

Cancer Drug Coverage Parity Act of 2013

referredUnited States· United States Congress· EN

Introduced

26 April 2013

Last action

8 July 2013 · Referred

Status

Referred to the Subcommittee on Health, Employment, Labor, and Pensions.

Sponsors

Rep. Higgins, Brian [D-NY-26], Rep. Moore, Gwen [D-WI-4], Rep. Pingree, Chellie [D-ME-1], Rep. Cicilline, David N. [D-RI-1], Rep. Capps, Lois [D-CA-24], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Wilson, Frederica S. [D-FL-24], Rep. Hastings, Alcee L. [D-FL-20], Rep. King, Peter T. [R-NY-2], Rep. Rangel, Charles B. [D-NY-15], Rep. Larsen, Rick [D-WA-2], Rep. McGovern, James P. [D-MA-2], Rep. Peters, Scott H. [D-CA-50], Rep. Wolf, Frank R. [R-VA-10], Rep. Moran, James P. [D-VA-8], Rep. Farr, Sam [D-CA-20], Rep. Ellison, Keith [D-MN-5], Rep. Connolly, Gerald E. [D-VA-11], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Maloney, Carolyn B. [D-NY-12], Rep. Polis, Jared [D-CO-2], Rep. Engel, Eliot L. [D-NY-16], Rep. Ryan, Tim [D-OH-13], Rep. Pastor, Ed [D-AZ-4], Rep. Schwartz, Allyson Y. [D-PA-13], Rep. Langevin, James R. [D-RI-2], Rep. Huffman, Jared [D-CA-2], Rep. Wittman, Robert J. [R-VA-1], Rep. Bonamici, Suzanne [D-OR-1], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Israel, Steve [D-NY-3], Rep. Loebsack, David [D-IA-2], Rep. Braley, Bruce L. [D-IA-1], Rep. Tonko, Paul [D-NY-20], Rep. Enyart, William L. [D-IL-12], Rep. Lee, Barbara [D-CA-12], Rep. Frelinghuysen, Rodney P. [R-NJ-11], Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Carney, John C., Jr. [D-DE-At Large], Rep. Takano, Mark [D-CA-39], Rep. Titus, Dina [D-NV-1], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Michaud, Michael H. [D-ME-2], Rep. Lofgren, Zoe [D-CA-18], Rep. Pocan, Mark [D-WI-2], Rep. Holt, Rush [D-NJ-12], Rep. Latham, Tom [R-IA-3], Rep. Lynch, Stephen F. [D-MA-8]

Subjects

Healthcare

Source updated

23 March 2026

Healthcare

Official sourceDownload fileView documentsShare

Summary

Cancer Drug Coverage Parity Act of 2013 - Amends the Employee Retirement Income Security Act of 1974 (ERISA), the Public Health Service Act, and the Internal Revenue Code to require a group or individual health plan providing benefits with respect to anticancer medications administered by a health care provider to provide no less favorable coverage for prescribed, patient-administered anticancer medications used to kill, slow, or prevent the growth of cancerous cells and that have been approved by the Food and Drug Administration (FDA). Applies such requirement to medication that is prescribed based on a finding by the treating physician that the medication is: (1) medically necessary for the purpose of killing, slowing, or preventing the growth of cancerous cells in accordance with nationally accepted standards of medical practice; and (2) clinically appropriate in terms of type, frequency, extent site, and duration. Permits such coverage to be subject to the same cost-sharing applicable to anticancer medications administered by a health care provider under the plan. Prohibits a health plan from imposing an increase in out-of-pocket costs, reclassifying benefits with respect to anticancer medications, or applying more restrictive limitations on prescribed orally- or intravenously-administered or injected anticancer medications. Requires a plan to provide notice to each participant and beneficiary regarding the coverage required under this Act. Prohibits a health plan from taking specified actions to avoid the requirements of this Act. Requires the Medicare Payment Advisory Commission to assess how closing the Medicare part D donut hole affects Medicare coverage for orally-administered anticancer medications, with a particular focus on cost and accessibility.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 26 April 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 26 April 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 26 April 2013

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  4. 3 May 2013

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 3 June 2013

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 8 July 2013

    Referred

    Referred to the Subcommittee on Health, Employment, Labor, and Pensions.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 26 April 2013

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 26 April 2013

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 26 April 2013

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 96 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.